These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15023718)

  • 1. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

  • 2. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus.
    Snow V; Weiss KB; Mottur-Pilson C;
    Ann Intern Med; 2003 Apr; 138(7):587-92. PubMed ID: 12667031
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension in type 2 diabetes--targeting angiotensin.
    Drug Ther Bull; 2005 Jun; 43(6):41-5. PubMed ID: 15966556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. Blood pressure control in people with type 2 diabetes mellitus: recommendations from the American College of Physicians.
    American College of Physicians
    Ann Intern Med; 2003 Apr; 138(7):I70. PubMed ID: 12667047
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive treatments for adults with type 2 diabetes.
    Majumdar SR
    BMJ; 2016 Feb; 352():i560. PubMed ID: 26867645
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 8. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from trials in hypertensive type 2 diabetic patients.
    Ruilope LM
    Curr Hypertens Rep; 2003 Aug; 5(4):322-8. PubMed ID: 12844467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of antihypertensive drugs in patients with diabetes.
    Wu HY; Hung KY; Tu YK; Chien KL
    J Comp Eff Res; 2014 May; 3(3):213-5. PubMed ID: 24969144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antihypertensive drug therapy in diabetes mellitus].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1990; 84(21):1109-10. PubMed ID: 1980768
    [No Abstract]   [Full Text] [Related]  

  • 12. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
    Chazova IE; Mychka VB; Duishvili DE
    Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
    Apperloo EM; Pena MJ; de Zeeuw D; Denig P; Heerspink HJL
    Diabetes Obes Metab; 2018 Jun; 20(6):1377-1383. PubMed ID: 29345404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do angiotensin II receptor antagonists substitute angiotensin converting enzyme inhibitors in the treatment of high blood pressure?].
    González-Juanatey JR
    Rev Esp Cardiol; 2000 Jan; 53(1):4-12. PubMed ID: 10701316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotection with antihypertensive agents.
    Hilgers KF; Mann JF
    Lancet; 2002 May; 359(9318):1693; author reply 1693-4. PubMed ID: 12020551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease.
    Palmer AJ; Annemans L; Roze S; Lamotte M; Lapuerta P; Chen R; Gabriel S; Carita P; Rodby RA; de Zeeuw D; Parving HH
    Diabetes Care; 2004 Aug; 27(8):1897-903. PubMed ID: 15277414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection with antihypertensive agents.
    Cruickshank JM
    Lancet; 2002 May; 359(9318):1693; author reply 1693-4. PubMed ID: 12020550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.